{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,7]],"date-time":"2026-09-07T19:07:34Z","timestamp":1788808054620,"version":"build-2803163510"},"reference-count":26,"publisher":"Begell House","issue":"4","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Crit Rev Eukaryot Gene Expr"],"published-print":{"date-parts":[[2025]]},"abstract":"<p>Asthma represents a chronic disorder with aberrant immunological and inflammatory responses. We analyzed the levels and clinical significance of serum markers serum amyloid A (SAA) and immunoglobulin M (IgM) in &lt;i&gt;Mycoplasma pneumoniae &lt;\/i&gt;(MP)-infected children with asthma. MP-infected children were allocated into the Asthma (&lt;i&gt;n &lt;\/i&gt;&amp;#61; 64) and N-Asthma (&lt;i&gt;n&lt;\/i&gt; &amp;#61; 104) groups, with baseline information collected. Levels of IgE, c-reactive protein, procalcitonin, lactate dehydrogenase, aspartate aminotransferase, interleukin-4\/interferon-&amp;gamma; (IL-4\/IFN-&amp;gamma;), transforming growth factor &amp;beta;1 (TGF-\u03b21), SAA and IgM were determined by ELISA. Tidal breathing lung function &amp;#91;inspiratory time (TI), expiratory time (TE), inspiratory volume (V-TI), expiratory volume (V-TE), tidal volume (VT) and respiratory rate (RR)&amp;#93; was assessed using a pulmonary function instrument. The relationship of serum SAA and IgM with IgE, IL-4\/IFN-&amp;gamma;, TGF-&amp;beta;1, and tidal breathing lung function in MP-infected asthmatic children, and their diagnostic value for asthma occurrence in MP-infected children were analyzed by Spearman analysis and receiver operating characteristic curve. IgE, V-TI, V-TE, VT, IL-4\/IFN-&amp;gamma;, TGF-&amp;beta;1, SAA and IgM indexes in MP-infected asthmatic children surpassed those without asthma. Serum SAA and IgM significantly positively correlated with IgE, IL-4\/IFN-&amp;gamma;, TGF-&amp;beta;1, V-TI, V-TE and VT, which had certain diagnostic value for asthma in MP-infected children. The incidence of asthma was higher in MP-infected children with high SAA and IgM expression levels. The diagnostic efficacy of SAA and IgM combined test surpassed single detection. Serum SAA and IgM were highly expressed in MP-infected asthmatic children, and their combined detection had high diagnostic value for asthma in MP-infected children.\n<\/p>","DOI":"10.1615\/critreveukaryotgeneexpr.2025056739","type":"journal-article","created":{"date-parts":[[2025,1,24]],"date-time":"2025-01-24T16:00:13Z","timestamp":1737734413000},"page":"27-37","source":"Crossref","is-referenced-by-count":5,"title":["Changes in the Levels of the Serum Markers Serum Amyloid A and Immunoglobulin M in Children with Mycoplasma pneumoniae Infection Complicated with Asthma and Their Clinical Significance"],"prefix":"10.1615","volume":"35","author":[{"given":"Shanshan","family":"Xiao","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xuejing","family":"Hou","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"613","reference":[{"key":"2","doi-asserted-by":"crossref","unstructured":"Kumar S. Mycoplasma pneumoniae: A significant but underrated pathogen in paediatric community-acquired lower respiratory tract infections. Indian J Med Res. 2018;147(1):23-31.","DOI":"10.4103\/ijmr.IJMR_1582_16"},{"key":"3","doi-asserted-by":"crossref","unstructured":"Meyer Sauteur PM, Unger WWJ, van Rossum AMC, Berger C. The art and science of diagnosing mycoplasma pneumoniae infection. Pediatr Infect Dis J. 2018;37(11):1192-5.","DOI":"10.1097\/INF.0000000000002171"},{"key":"4","doi-asserted-by":"crossref","unstructured":"Gans MD, Gavrilova T. Understanding the immunology of asthma: Pathophysiology, biomarkers, and treatments for asthma endotypes. Paediatr Respir Rev. 2020;36:118-27.","DOI":"10.1016\/j.prrv.2019.08.002"},{"key":"5","doi-asserted-by":"crossref","unstructured":"Mims JW. Asthma: Definitions and pathophysiology. Int Forum Allergy Rhinol. 2015;5(Suppl 1):S2-6.","DOI":"10.1002\/alr.21609"},{"key":"6","doi-asserted-by":"crossref","unstructured":"Miller RL, Grayson MH, Strothman K. Advances in asthma: New understandings of asthma's natural history, risk factors, underlying mechanisms, and clinical management. J Allergy Clin Immunol. 2021;148(6):1430-41.","DOI":"10.1016\/j.jaci.2021.10.001"},{"key":"7","unstructured":"Smith-Norowitz TA, Loeffler J, Huang Y, Norowitz YM, Joks R, Kohlhoff S. Comparison of mycoplasma pneumoniae IgM and IgE antibody levels in asthmatic and non-asthmatic adults. Ann Clin Lab Sci. 2021;51(4):540-5."},{"key":"8","doi-asserted-by":"crossref","unstructured":"Sack GH, Jr. Serum amyloid A (SAA) proteins. Subcell Biochem. 2020;94:421-36.","DOI":"10.1007\/978-3-030-41769-7_17"},{"key":"9","doi-asserted-by":"crossref","unstructured":"Jiang Y, Wang W, Zhang Z, Ma X, Sang Y, Wang J, Xu G, Feng Q, Zhao S. Serum amyloid a, C-reactive protein, and procalcitonin levels in children with mycoplasma pneumoniae infection. J Clin Lab Anal. 2022;36(3):e24265.","DOI":"10.1002\/jcla.24265"},{"key":"10","doi-asserted-by":"crossref","unstructured":"Smith-Norowitz TA, Shulman A, Abdelmajid H, Hammerschlag MR, Joks R, Weaver D, Kohlhoff S. Chlamydia pneumoniae-immunoglobulin E antibody responses in serum from children with asthma. Pathog Dis. 2023;81:ftad015","DOI":"10.1093\/femspd\/ftad015"},{"key":"11","doi-asserted-by":"crossref","unstructured":"Hendeles L, Sorkness CA. Anti-immunoglobulin E therapy with omalizumab for asthma. Ann Pharmacother. 2007;41(9):1397-410.","DOI":"10.1345\/aph.1K005"},{"key":"12","doi-asserted-by":"crossref","unstructured":"Atkinson TP, Balish MF, Waites KB. Epidemiology, clinical manifestations, pathogenesis and laboratory detection of Mycoplasma pneumoniae infections. FEMS Microbiol Rev. 2008;32(6):956-73.","DOI":"10.1111\/j.1574-6976.2008.00129.x"},{"key":"13","doi-asserted-by":"crossref","unstructured":"Liu L, Gao Y, Si Y, Liu B, Liu X, Li G, Wang R. MALT1 in asthma children: A potential biomarker for monitoring exacerbation risk and Th1\/Th2 imbalance-mediated inflammation. J Clin Lab Anal. 2022;36(5):e24379.","DOI":"10.1002\/jcla.24379"},{"key":"14","doi-asserted-by":"crossref","unstructured":"Huang HR, Zhong YQ, Wu JF. The association between IFN-gamma and IL-4 genetic polymorphisms and childhood susceptibility to bronchial asthma. Gene. 2012;494(1):96-101.","DOI":"10.1016\/j.gene.2011.09.027"},{"key":"15","doi-asserted-by":"crossref","unstructured":"Yang Y, Zhou Y. Shashen-Maidong decoction-mediated IFN-gamma and IL-4 on the regulation of Th1\/Th2 imbalance in RP rats. Biomed Res Int. 2019;2019:6012473.","DOI":"10.1155\/2019\/6012473"},{"key":"16","doi-asserted-by":"crossref","unstructured":"Cianchetti S, Cardini C, Puxeddu I, Latorre M, Bartoli ML, Bradicich M, Dente F, Bacci E, Celi A, Paggiaro P. Distinct profile of inflammatory and remodelling biomarkers in sputum of severe asthmatic patients with or without persistent airway obstruction. World Allergy Organ J. 2019;12(11):100078.","DOI":"10.1016\/j.waojou.2019.100078"},{"key":"17","doi-asserted-by":"crossref","unstructured":"Januskevicius A, Vaitkiene S, Gosens R, Janulaityte I, Hoppenot D, Sakalauskas R, Malakauskas K. Eosinophils enhance WNT-5a and TGF-beta1 genes expression in airway smooth muscle cells and promote their proliferation by increased extracellular matrix proteins production in asthma. BMC Pulm Med. 2016;16(1):94.","DOI":"10.1186\/s12890-016-0254-9"},{"key":"18","unstructured":"Han W, Xie Y, Ren SY, Yin LM, Fen XY, Deng XH, Xin HX. Clinical application of tidal breathing lung function test in 1-4 years old children with wheezing diseases. Zhongguo Dang Dai Er Ke Za Zhi. 2014;16(8):800-4 (in Chinese)."},{"key":"19","doi-asserted-by":"crossref","unstructured":"Escobar H, Carver TW, Jr. Pulmonary function testing in young children. Curr Allergy Asthma Rep. 2011;11(6):473-81.","DOI":"10.1007\/s11882-011-0220-9"},{"key":"20","doi-asserted-by":"crossref","unstructured":"Diaconu ID, Gheorman V, Grigorie GA, Gheonea C, Tenea-Cojan TS, Mahler B, Voropanov IA, Firoiu MC, Pirvu AS, Popescu AB, Varut R. A comprehensive look at the development of asthma in children. Children. 2024;11(5):581.","DOI":"10.3390\/children11050581"},{"key":"21","doi-asserted-by":"crossref","unstructured":"Ojo RO, Okobi OE, Ezeamii PC, Ezeamii VC, Nwachukwu EU, Gebeyehu YH, Okobi E, David AB, Akinsola Z. Epidemiology of current asthma in children under 18: A two-decade overview using national center for health statistics (NCHS) data. Cureus. 2023;15(11):e49229.","DOI":"10.7759\/cureus.49229"},{"key":"22","doi-asserted-by":"crossref","unstructured":"Yao X, Kaler M, Qu X, Kalidhindi RSR, Sviridov D, Dasseux A, Barr E, Keeran K, Jeffries KR, Yu ZX, Gao M, Gordon S, Barochia AV, Mills J, Shahid S, Weir NA, Kalchiem-Dekel O, Theard P, Playford MP, Stylianou M, Fitzgerald W, Remaley AT, Levine SJ. Asthmatic patients with high serum amyloid A have proinflammatory HDL: Implications for augmented systemic and airway inflammation. J Allergy Clin Immunol. 2024;153(4):1010-24.e14.","DOI":"10.1016\/j.jaci.2023.11.917"},{"key":"23","doi-asserted-by":"crossref","unstructured":"Bich TCT, Quoc QL, Choi Y, Yang EM, Trinh HKT, Shin YS, Park HS. Serum amyloid A1: A biomarker for neutrophilic airway inflammation in adult asthmatic patients. Allergy Asthma Immunol Res. 2022;14(1):40-58.","DOI":"10.4168\/aair.2022.14.1.40"},{"key":"24","doi-asserted-by":"crossref","unstructured":"Buyukozturk S, Gelincik AA, Genc S, Kocak H, Oneriyidogan Y, Erden S, Dal M, Colakoglu B. Acute phase reactants in allergic airway disease. Tohoku J Exp Med. 2004;204(3):209-13.","DOI":"10.1620\/tjem.204.209"},{"key":"25","doi-asserted-by":"crossref","unstructured":"Rath N, Raje N, Rosenwasser L. Immunoglobulin E as a biomarker in asthma. Immunol Allergy Clin North Am. 2018;38(4):587-97.","DOI":"10.1016\/j.iac.2018.06.007"},{"key":"26","doi-asserted-by":"crossref","unstructured":"Jousilahti P, Salomaa V, Hakala K, Rasi V, Vahtera E, Palosuo T. The association of sensitive systemic inflammation markers with bronchial asthma. Ann Allergy Asthma Immunol. 2002;89(4):381-5.","DOI":"10.1016\/S1081-1206(10)62039-X"},{"key":"27","doi-asserted-by":"crossref","unstructured":"Vietri L, Fui A, Bergantini L, d'Alessandro M, Cameli P, Sestini P, Rottoli P, Bargagli E. Serum amyloid A: A potential biomarker of lung disorders. Respir Investig. 2020;58(1):21-7.","DOI":"10.1016\/j.resinv.2019.09.005"}],"container-title":["Critical Reviews in Eukaryotic Gene Expression"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.dl.begellhouse.com\/download\/article\/051ef31a22722f48\/CRE-56739.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,4,15]],"date-time":"2025-04-15T09:00:26Z","timestamp":1744707626000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.dl.begellhouse.com\/journals\/6dbf508d3b17c437,66977548085bae20,051ef31a22722f48.html"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025]]},"references-count":26,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2025]]}},"URL":"https:\/\/doi.org\/10.1615\/critreveukaryotgeneexpr.2025056739","relation":{},"ISSN":["1045-4403"],"issn-type":[{"value":"1045-4403","type":"print"}],"subject":[],"published":{"date-parts":[[2025]]}}}